<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03547102</url>
  </required_header>
  <id_info>
    <org_study_id>115229/02</org_study_id>
    <nct_id>NCT03547102</nct_id>
  </id_info>
  <brief_title>Effect of Cherry Concentrate on Brain Activation and Perfusion in Healthy Older Adults</brief_title>
  <official_title>Effect of Cherry Concentrate on Brain Activation and Perfusion in Healthy Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Exeter</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Exeter</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effect of 8 weeks of cherry concentrate supplementation on cognitive function and brain
      perfusion in healthy older adults
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will perform a double blind, randomised controlled study to determine
      whether cherry polyphenols improve peripheral vascular function and cerebral perfusion
      resulting in improved task related brain activation and cognitive function. 30 healthy
      elderly men and women 60-85y years will be recruited to complete 8-week supplementation with
      MC concentrate or an isoenergetic cherry placebo concentrate. Participants will be pair
      matched for age, sex, and cognitive function (Adenbrooke's Cognitive Examination III,
      ACE-III) and then randomised using a sealed envelope system to receive either placebo or
      cherry.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain perfusion</measure>
    <time_frame>Change from baseline to 8 weeks supplementation</time_frame>
    <description>Arterial spin labelling using MRI, measure will be reported as ml/min</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>Change from baseline to 8 weeks supplementation</time_frame>
    <description>Battery of cognitive function tasks assessing executive function, global cognitive function score will be reported</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain activation (fMRI)</measure>
    <time_frame>Change from baseline to 8 weeks supplementation</time_frame>
    <description>fMRI using a hippocampal biased task</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma nitrite concentration</measure>
    <time_frame>Change from baseline to 8 weeks supplementation</time_frame>
    <description>Plasma sample analysed via chemiluminescence technique</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Cherry concentrate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8 weeks supplementation with montmorency cherry concentrate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo concentrate</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>8 weeks supplementation with placebo isoenergetic cherry concentrate</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cherry concentrate</intervention_name>
    <arm_group_label>Cherry concentrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo concentrate</intervention_name>
    <arm_group_label>Placebo concentrate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  physically inactive consuming 5 or less portions of fruit per day Addenbrookes
             cognitive examination III score &gt;88

        Exclusion Criteria:

          -  physically active consuming more than 5 portions of fruit per day Addenbrookes
             cognitive examination III score &lt;88 Contraindications for MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joanna L Bowtell, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Exeter</affiliation>
  </overall_official>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>December 2, 2016</study_first_submitted>
  <study_first_submitted_qc>May 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2018</study_first_posted>
  <last_update_submitted>June 21, 2018</last_update_submitted>
  <last_update_submitted_qc>June 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

